CapsoVision CV
NASDAQ CV
$6.37 +0.01 (+0.16%)
At close: Sep 9, 2026 · 4:00 PM EDT

CapsoVision (CV) Enterprise Value (2025 - 2026)

CapsoVision's (CV) quarterly Enterprise Value came in at $370.2 million in Q2 2026, up 46.67% quarter-over-quarter from $252.4 million in Q4 2025.

Analysis

CapsoVision (CV) Enterprise Value (2025 - 2026) Analysis & Trends

CapsoVision has disclosed Enterprise Value across 2 years of filings, most recently posting $370.2 million for Q2 2026.

  • In Q2 2026, Enterprise Value changed N/A year-over-year to $370.2 million; the TTM figure through Jun 2026 stood at $370.2 million (changed N/A YoY), while the FY2025 annual figure was $252.4 million, changed N/A from the prior year.
  • Enterprise Value came in at $370.2 million for Q2 2026 at CapsoVision, up from $252.4 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of $370.2 million in Q2 2026 to a low of $64.7 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 GE HealthCare Technologies 29.54 Bn 27.44 Bn 2.18 Bn
2 Lantheus Holdings 6.56 Bn 5.97 Bn 241.86 Mn
3 Heartflow 4.04 Bn 3.66 Bn 53.19 Mn
4 Neogen 2.59 Bn 2.41 Bn 107.80 Mn
5 Butterfly Network 1.96 Bn 1.84 Bn 23.29 Mn
6 Ceribell 928.74 Mn 799.48 Mn 25.94 Mn
7 QuidelOrtho 866.04 Mn 742.64 Mn -
8 Varex Imaging 779.06 Mn 679.86 Mn 76.70 Mn
9 Prenetics Global 339.99 Mn 280.94 Mn 30.20 Mn
10 CapsoVision 318.60 Mn 309.52 Mn 1.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 370.17 Mn
Dec 31, 2025 252.39 Mn
Sep 30, 2025 64.73 Mn